Catch up on what happened in optometry during the week of June 5-June 9.
Catch up with what Optometry Times®' shared this week:
Chris Wroten, OD
Who doesn’t love a good joke? One definition of funny is “strange or odd,” and we’ve all got our strange tales from the exam room. Here are a couple of mine and what I learned from them.
Emily Kaiser, Assistant Managing Editor
Bausch + Lomb announced the United States launch of their Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses. The lenses leverage Bausch + Lomb’s ProBalance Technology and their proprietary 3-Zone Progressive design to deliver all-day comfort and seamless transitions across near, intermediate, and distance vision in the hopes of meeting the dynamic vision needs of patients with presbyopia.1
Kassi Jackson, Editor
Glaukos has announced the completion of enrollment and randomization in its second phase 3 confirmatory pivotal trial for Epioxa (Epi-on), the company’s second-generation corneal cross-linking therapy for the treatment of keratoconus. Glaukos is expected to file a New Drug Application (NDA) with the US Food and Drug Administration (FDA) by the end of 2024.1
Glenda Aleman Moheeputh, OD; Kassi Jackson, Editor
Glenda Aleman Moheeputh, OD, president and CEO of OK Love Myopia Control Experts in Florida, sat down with Optometry Times®' editor Kassi Jackson to talk about her role on the founding board of Latinos en Optometry (LEO).
Founded by Diana Canto-Sims, OD, LEO has 5 goals:
The founding board of Latinos En Optometry includes Diana Canto-Sims, OD, CEO, Founder and Stylist of La Vida Eyewear and Co-Owner of Buena Vista Optical in Chicago, IL; Lawrence Chavez, Founder & CEO of EveryDay Contacts; Howard Purcell, OD, President and CEO of the New England College of Optometry; Hector Santiago, OD, PhD, Professor and Director of Research Activities at Inter American University of Puerto Rico School of Optometry; Glenda Aleman Moheeputh, OD, Founder and CEO of OK Love Myopia Control Experts; Karen Carrasquillo, OD, PhD, Senior Vice President Clinical and Professional Affairs at BostonSight; Diana Shechtman, OD, Fellow at the American Academy of Optometry and Optometric Retinal Society; and Lina Arango, OD, who currently works as an Independent Doctor with LTA Vision corporation.
Leo P. Semes, OD, FAAO
Lattice retinal degeneration is the most significant peripheral retinal change associated with retinal detachment. Generally, it is a stable condition without symptoms unless the complication of a retinal tear develops, which can lead to retinal detachment. There are a number of presentations among patients, who can be of a young age and have almost any refractive correction.
Optometry Times Staff Reports; Kassi Jackson, Editor
The National Keratoconus Foundation (NKCF) has named NASCAR driver Joey Gase as ambassador.
Gase, from Cedar Rapids, Iowa, discovered his lifelong passion when he won the first of many Go-Kart races at age 8. By 18, Joey had been signed as a professional driver and was competing in the NASCAR Nationwide Series. Today, Joey is driver and co-owner of Emerling-Gase Motorsports and has competed in more than 350 NASCAR events.
The NKCF is the world’s oldest and largest organization dedicated to increasing awareness of keratoconus (KC), a bilateral eye disease characterized by progressive thinning and bulging of the cornea which results in vision impairment.
The American Optometric Association (AOA) Optometry’s Meeting will convene its 126th annual congress from Wednesday, June 21 to Saturday, June 24, 2023, in Washington, DC, at the Walter E. Washington Convention Center.
The meeting provides opportunity for optometric continuing education and professional development, with networking and business opportunities among colleagues, industry professionals, and the profession's leaders.
Thomas A. Wong, OD, FNAP; Marin Nagelberg, BS; Travis Pfeifer, BA; Sharon P. Keh OD, FAAO
Scleral contact lenses are becoming more popular because of their unique design. Unlike other contact lenses, scleral lenses vault over the cornea and rest on the conjunctiva overlying the sclera. This makes them more comfortable than other types of gas permeable contact lenses, and allows them to be used to correct a wider range of vision problems.
For patients who wear scleral lenses for therapeutic purposes, it is important to manage their relevant corneal disease, ocular surface disease, and refractive error.1 For these patients, comanagement of their underlying ocular and systemic conditions is often the key to success.
Kassi Jackson, Editor
The second annual local vision clinic hosted by the North America affiliate of the OneSight EssilorLuxottica Foundation in partnership with Transitions was held last month in Orlando. The clinic aims to address the unmet needs of 83 local Pathlight HOME clients who may have otherwise lacked access to eye exams and glasses.
After last year’s clinic, seeing the positive role the comprehensive eye exams played in Orlando, Transitions and Transitions Optical’s Diversity Advisory Board wanted to provide the opportunity for the second year in a row.